vimarsana.com
Home
Live Updates
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 : vimarsana.com
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
Pooled analysis of the FELIX Phase Ib/II study demonstrated prolonged event free survival and low overall immunotoxicity across all cohorts in r/r B-ALL, and particularly in patients with low leukemic...
Related Keywords
London ,
City Of ,
United Kingdom ,
San Diego ,
California ,
United States ,
San Diego Convention Center ,
American ,
Julia Wilson ,
Lauren Williams ,
Lydia Lee ,
Obecabtagene Autoleucel ,
Claire Roddie ,
Susana Noonan ,
Consultant Haematologist Senior Clinical Research ,
American Society Of Hematology ,
Sa Noonan Communications ,
Globenewswire Inc ,
Drug Administration ,
Exchange Commission ,
Cancer Institute ,
Research Department Of Haematology ,
University College London ,
Nasdaq ,
Annual Meeting ,
Associate Professor Haematology ,
Honorary Consultant Haematologist ,
College London ,
Chief Executive Officer ,
Biologics License Application ,
B Cell Acute Lymphoblastic Leukemia ,
Pooled Analysis ,
Early Phase ,
Investigational Therapies ,
Expanding Disease Targets ,
Diego Convention Center ,
Phasei Study Evaluating ,
Multiple Myeloma ,
Translational Insights ,
Consultant Haematologist ,
Senior Clinical Research Fellow ,
Long Term Efficacy ,
Adult Patients ,
Refractoryb Cell Acute Lymphoblastic Leukemia ,
Poster Session ,
Hallsg H ,
Study Demonstrating Robust Cell Processing ,
Robust Release Testing ,
Reliable Logistics ,
Sustainable Patient ,
Investor Event ,
Manchester Grand Hyatt ,
Private Securities Litigation Reform Act ,
Annual Report ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.